Bone morphogenetic protein 7

DRUG2 trials

Sponsors

Stryker Biotech

Conditions

Osteoarthritis of the Knee

Phase 1

Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

CompletedNCT01133613

Stryker BiotechOsteoarthritis of the Knee

Start: 2010-05-31End: 2011-10-31Updated: 2012-02-01

Phase 2

Dose Finding Study of Bone Morphogenetic Protein 7 (BMP-7) in Subjects With Osteoarthritis (OA) of the Knee

CompletedNCT01111045

Stryker BiotechOsteoarthritis of the Knee

Start: 2010-04-30End: 2011-08-31Updated: 2012-02-01